Sjögren’s Syndrome
Clinical Trials
Scientists at OMRF invite you to participate in a clinical trial for a new treatment for Sjögren’s syndrome. The purpose of the study is to determine if the experimental study agent, baminercept, is effective in treating patients with Sjögren’s. If you are between the ages of 18 and 75 and have been diagnosed with Sjögren’s, you may qualify for participation. For more information, contact:
Sheryl Delancy, RN
(405) 271-8001, ext. 34400
sheryl-delancy@omrf.org